Russell Investments Group
OBIO icon

Russell Investments Group’s Orchestra BioMed OBIO Stock Holding History

Russell Investments Group’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-193
Closed -$517 – 4200
2025
Q2 		$517 Buy
+193
New +$563 ﹤0.01% 3741
2025
Q1 		– Sell
-125
Closed -$500 – 3855
2024
Q4 		$500 Sell
125
-198
-61% -$1.06K ﹤0.01% 3610
2024
Q3 		$1.66K Sell
323
-3,527
-92% -$23K ﹤0.01% 3407
2024
Q2 		$31.4K Buy
+3,850
New +$22.3K ﹤0.01% 2865
2023
Q4 		– Sell
-91
Closed -$794 – 3279
2023
Q3 		$794 Buy
+91
New +$612 ﹤0.01% 3360

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group's OBIO Position: Q3 2025 in Review

Russell Investments Group sold out of Orchestra BioMed (OBIO) in Q3 2025, closing a stake of 193 shares — an estimated $517 sold.

Russell Investments Group first reported a position in OBIO in Q3 2023 and held it in 5 quarters. The position peaked at $31.4K in Q2 2024. 52 funds tracked by Wall St. Rank hold OBIO as of Q3 2025.

  • Russell Investments Group reported no remaining Orchestra BioMed position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 193 Orchestra BioMed shares in Q3 2025, an estimated $517.
  • Russell Investments Group first reported a position in Orchestra BioMed in Q3 2023 and held it in 5 quarters.
  • Russell Investments Group's Orchestra BioMed position peaked at $31.4K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.